iShares Biotechnology ETF
เพิ่มขึ้น

Biotech Double Bottom (+ Divergence & Bollinger Reversal)

ที่อัปเดต:
Technical Analysis
1. As you see in the chart, we have tested the 200ema 3 times in the past; and it has not trade below it since April 2020.
We have made a spinning-bottom on a downtrend, coincidental with a 4th test of the 200ema.

2. RSI and OBV show a positive divergence as the bottom from 2 weeks ago (Test #3) was at a lower level.

3. Bollinger Bands give us another bullish signal, as the first low (Test #3) was outside the lower BB, and the second low (Test #4) was inside the lower BB.

Trade Setup
A break below Test #3 which is $142.47 could be a potentially good place to set a stop-loss exit.
Short-term target to the upside --> $160.5
Mid-term target to the upside --> $170


Trade with care
บันทึก
Looks like a successful test of the 200ema.
50sma is the next resistance around $159.
AMGNbiotechbollingerbandstrategyChart PatternsDivergenceDouble BottomTechnical IndicatorsMRNAobvdivergencereversalpatternspinningbottomTrend Analysis

คำจำกัดสิทธิ์ความรับผิดชอบ